Inhibitory Effects of Gyeongok-go on Lung Injury in a Chronic Obstructive Pulmonary Disease Mouse Model
Pharmaceuticals · 14.04.2026 · 19 (4) · 618
DOI: 10.3390/ph19040618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 14.04.2026. Verfasst von Won-Kyung Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 34520, Republic of Korea. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic o…, the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), Korea Health Technology R&D Project through the Korea Health Industry Development Institute.
Themen: COPD
Abstract (Originalsprache)
Background/Objectives: Chronic obstructive pulmonary disease (COPD) is characterized by incomplete recovery of airflow blockage; however, effective therapeutic agents that can prevent lung function deterioration are limited. East Asian herbal treatments have gained attention for their potential benefits in managing COPD. This study aimed to evaluate the inhibitory effects of Gyeongok-go (GOG) on lung injury in a COPD mouse model.
Methods
Lipopolysaccharide (LPS)-induced alveolar macrophage (MH-S) cells were treated with GOG (50, 100, 200, and 400 μg/mL), and analyzed using enzyme-linked immunosorbent assay (ELISA). C57BL/6 mice were challenged with cigarette smoke extract and LPS and then treated with vehicle only, dexamethasone (3 mg/kg), or GOG (100, 200, or 400 mg/kg). Bronchoalveolar lavage fluid (BALF) or lung tissues were analyzed using cytospin, ELISA, real-time PCR, flow cytometry, hematoxylin and eosin, and Masson’s trichrome staining.
Results
Treatment with GOG decreased tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 expression in LPS-challenged MH-S cells. In COPD mice, GOG significantly decreased the elevated numbers of neutrophils, total cells, macrophages, and Gr-1+/Siglec-F, Gr-1+/CD11b+, and CD44high/CD62L− cells. It also downregulated the expression of TNF-α, IL-17A, macrophage inflammatory protein-2 (MIP2), and CXC chemokine ligand-1 in BALF. GOG also inhibited the increase in Mip2, Cox-2, and Trpv1 mRNA expression. Moreover, GOG prevented the increase in the number of total cells, neutrophils, Gr-1+/Siglec-F, Gr-1+/CD11b+, CD44high/CD62L−, and CD21+/CD35+/B220+ cells in lung tissues. Notably, GOG decreased the severity of lung injury.
Conclusions
Overall, these findings indicate that GOG alleviates lung injury, suggesting its potential in the treatment of COPD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 34520, Republic of Korea.
- Division of Respiratory Medicine, Department of Internal Medicine, College of Korean Medicine, Daejeon University, Daejeon 34520, Republic of Korea.
- KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
ORCID-Profile: Won-Kyung Yang, Seung-Hyung Kim, Su Won Lee, Yee Ran Lyu, Yang-Chun Park
Förderung
- the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic o…
- the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute
- Ministry of Health & Welfare, Republic of Korea
- National Research Foundation of Korea
- Korea government
Zitieren
APA
Yang, W. K., Choi, J. K., Kim, S. H., Lee, S. W., Lyu, Y. R., & Park, Y. C. (2026). Inhibitory Effects of Gyeongok-go on Lung Injury in a Chronic Obstructive Pulmonary Disease Mouse Model. Pharmaceuticals, 19(4), 618. https://doi.org/10.3390/ph19040618
Vancouver
Yang WK, Choi JK, Kim SH, Lee SW, Lyu YR, Park YC. Inhibitory Effects of Gyeongok-go on Lung Injury in a Chronic Obstructive Pulmonary Disease Mouse Model. Pharmaceuticals. 2026;19(4):618. doi:10.3390/ph19040618
BibTeX
@article{Yang2026,
author = {Yang, Won-Kyung and Choi, Jin Kwan and Kim, Seung-Hyung and Lee, Su Won and Lyu, Yee Ran and Park, Yang-Chun},
title = {Inhibitory Effects of Gyeongok-go on Lung Injury in a Chronic Obstructive Pulmonary Disease Mouse Model},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {4},
pages = {618},
doi = {10.3390/ph19040618}
}
EUVIMED